Staffing shortages and a backlog of surgeries define the post-COVID-19 recovery in healthcare. To resolve these issues, Katya Zubareva explains, L.E.K. helps providers develop two approaches in parallel.
Biotech and Pharmaceuticals
Improving the Understanding Acceptance and Use of Oncology–Relevant Endpoints
Life Sciences & Pharma
Initial Drugs Selected for Medicare Price Negotiation: Emerging Perspectives